HALEOS LABS
Back to Balance Sheet
|
HALEOS LABS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹151 Cr | ₹149 Cr | ₹137 Cr | ₹143 Cr | ₹119 Cr |
What is the latest Total Current Liabilities ratio of HALEOS LABS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹151 Cr |
| Mar2024 | ₹149 Cr |
| Mar2023 | ₹137 Cr |
| Mar2022 | ₹143 Cr |
| Mar2021 | ₹119 Cr |
How is Total Current Liabilities of HALEOS LABS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹151 Cr | 1.52 | |
| Mar2024 | ₹149 Cr | 8.57 | |
| Mar2023 | ₹137 Cr | -4.19 | |
| Mar2022 | ₹143 Cr | 20.46 | |
| Mar2021 | ₹119 Cr | - | |
Compare Total Current Liabilities of peers of HALEOS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HALEOS LABS | ₹487.1 Cr | 4.6% | 20.2% | 21% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
HALEOS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HALEOS LABS | 4.6% |
20.2% |
21% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses